CBA
ALNY icon

Coastal Bridge Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Coastal Bridge Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283K Sell
941
-46
-5% -$13.9K 0.02% 403
2026
Q1 		$327K Sell
987
-61
-6% -$20.8K 0.02% 367
2025
Q4 		$417K Sell
1,048
-49
-4% -$21.7K 0.03% 328
2025
Q3 		$500K Buy
1,097
+25
+2% +$10.2K 0.04% 296
2025
Q2 		$350K Sell
1,072
-64
-6% -$17.7K 0.03% 335
2025
Q1 		$307K Buy
+1,136
New +$292K 0.03% 337

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Coastal Bridge Advisors's ALNY Position: Q2 2026 in Review

Coastal Bridge Advisors reduced its Alnylam Pharmaceuticals (ALNY) stake by 4.7% in Q2 2026, selling an estimated $13.9K and leaving 941 shares worth $283K. The position accounts for 0.02% of the portfolio, ranked #403.

Coastal Bridge Advisors first reported a position in ALNY in Q1 2025 and has held it in 6 quarters since. The position peaked at $500K in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Coastal Bridge Advisors held 941 shares of Alnylam Pharmaceuticals worth $283K as of Q2 2026.
  • Coastal Bridge Advisors sold 46 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $13.9K.
  • Alnylam Pharmaceuticals made up 0.02% of Coastal Bridge Advisors's portfolio in Q2 2026, its #403 holding.
  • Coastal Bridge Advisors first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Coastal Bridge Advisors's Alnylam Pharmaceuticals position peaked at $500K in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Coastal Bridge Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.